Cite

    Melo-Carrillo, A. et al. (2020). Fremanezumab and its isotype slow propagation rate and shorten cortical recovery period but do not prevent occurrence of cortical spreading depression in rats with compromised blood–brain barrier. Pain. 161 (5), p. . [Online].